Cargando…

The palladacycle complex AJ-5 induces apoptotic cell death while reducing autophagic flux in rhabdomyosarcoma cells

Rhabdomyosarcoma (RMS) forms in skeletal muscle and is the most common soft tissue sarcoma in children and adolescents. Current treatment is associated with debilitating side effects and treatment outcomes for patients with metastatic disease are dismal. Recently, a novel binuclear palladacycle, AJ-...

Descripción completa

Detalles Bibliográficos
Autores principales: Bleloch, Jenna Susan, du Toit, André, Gibhard, Liezl, Kimani, Serah, Ballim, Reyna Deeya, Lee, Minkyu, Blanckenberg, Angelique, Mapolie, Selwyn, Wiesner, Lubbe, Loos, Ben, Prince, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349869/
https://www.ncbi.nlm.nih.gov/pubmed/30701092
http://dx.doi.org/10.1038/s41420-019-0139-9
_version_ 1783390337330315264
author Bleloch, Jenna Susan
du Toit, André
Gibhard, Liezl
Kimani, Serah
Ballim, Reyna Deeya
Lee, Minkyu
Blanckenberg, Angelique
Mapolie, Selwyn
Wiesner, Lubbe
Loos, Ben
Prince, Sharon
author_facet Bleloch, Jenna Susan
du Toit, André
Gibhard, Liezl
Kimani, Serah
Ballim, Reyna Deeya
Lee, Minkyu
Blanckenberg, Angelique
Mapolie, Selwyn
Wiesner, Lubbe
Loos, Ben
Prince, Sharon
author_sort Bleloch, Jenna Susan
collection PubMed
description Rhabdomyosarcoma (RMS) forms in skeletal muscle and is the most common soft tissue sarcoma in children and adolescents. Current treatment is associated with debilitating side effects and treatment outcomes for patients with metastatic disease are dismal. Recently, a novel binuclear palladacycle, AJ-5, was shown to exert potent cytotoxicity in melanoma and breast cancer and to present with negligible adverse effects in mice. This study investigates the anti-cancer activity of AJ-5 in alveolar and embryonal RMS. IC(50) values of ≤ 0.2 µM were determined for AJ-5 and it displayed a favourable selectivity index of >2. Clonogenic and migration assays showed that AJ-5 inhibited the ability of RMS cells to survive and migrate, respectively. Western blotting revealed that AJ-5 induced levels of key DNA damage response proteins (γH2AX, p-ATM and p-Chk2) and the p38/MAPK stress pathway. This correlated with an upregulation of p21 and a G(1) cell cycle arrest. Annexin V-FITC/propidium iodide staining revealed that AJ-5 induced apoptosis and necrosis. Apoptosis was confirmed by the detection of cleaved PARP and increased levels and activity of cleaved caspases-3, -7, -8 and -9. Furthermore, AJ-5 reduced autophagic flux as shown by reduced LC3II accumulation in the presence of bafilomycin A1 and a significant reduction in autophagosome flux J. Finally, pharmacokinetic studies in mice show that AJ-5 has a promising half-life and that its volume of distribution is high, its clearance low and its intraperitoneal absorption is good. Together these findings suggest that AJ-5 may be an effective chemotherapeutic with a desirable mechanism of action for treating drug-resistant and advanced sarcomas.
format Online
Article
Text
id pubmed-6349869
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63498692019-01-30 The palladacycle complex AJ-5 induces apoptotic cell death while reducing autophagic flux in rhabdomyosarcoma cells Bleloch, Jenna Susan du Toit, André Gibhard, Liezl Kimani, Serah Ballim, Reyna Deeya Lee, Minkyu Blanckenberg, Angelique Mapolie, Selwyn Wiesner, Lubbe Loos, Ben Prince, Sharon Cell Death Discov Article Rhabdomyosarcoma (RMS) forms in skeletal muscle and is the most common soft tissue sarcoma in children and adolescents. Current treatment is associated with debilitating side effects and treatment outcomes for patients with metastatic disease are dismal. Recently, a novel binuclear palladacycle, AJ-5, was shown to exert potent cytotoxicity in melanoma and breast cancer and to present with negligible adverse effects in mice. This study investigates the anti-cancer activity of AJ-5 in alveolar and embryonal RMS. IC(50) values of ≤ 0.2 µM were determined for AJ-5 and it displayed a favourable selectivity index of >2. Clonogenic and migration assays showed that AJ-5 inhibited the ability of RMS cells to survive and migrate, respectively. Western blotting revealed that AJ-5 induced levels of key DNA damage response proteins (γH2AX, p-ATM and p-Chk2) and the p38/MAPK stress pathway. This correlated with an upregulation of p21 and a G(1) cell cycle arrest. Annexin V-FITC/propidium iodide staining revealed that AJ-5 induced apoptosis and necrosis. Apoptosis was confirmed by the detection of cleaved PARP and increased levels and activity of cleaved caspases-3, -7, -8 and -9. Furthermore, AJ-5 reduced autophagic flux as shown by reduced LC3II accumulation in the presence of bafilomycin A1 and a significant reduction in autophagosome flux J. Finally, pharmacokinetic studies in mice show that AJ-5 has a promising half-life and that its volume of distribution is high, its clearance low and its intraperitoneal absorption is good. Together these findings suggest that AJ-5 may be an effective chemotherapeutic with a desirable mechanism of action for treating drug-resistant and advanced sarcomas. Nature Publishing Group UK 2019-01-28 /pmc/articles/PMC6349869/ /pubmed/30701092 http://dx.doi.org/10.1038/s41420-019-0139-9 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Bleloch, Jenna Susan
du Toit, André
Gibhard, Liezl
Kimani, Serah
Ballim, Reyna Deeya
Lee, Minkyu
Blanckenberg, Angelique
Mapolie, Selwyn
Wiesner, Lubbe
Loos, Ben
Prince, Sharon
The palladacycle complex AJ-5 induces apoptotic cell death while reducing autophagic flux in rhabdomyosarcoma cells
title The palladacycle complex AJ-5 induces apoptotic cell death while reducing autophagic flux in rhabdomyosarcoma cells
title_full The palladacycle complex AJ-5 induces apoptotic cell death while reducing autophagic flux in rhabdomyosarcoma cells
title_fullStr The palladacycle complex AJ-5 induces apoptotic cell death while reducing autophagic flux in rhabdomyosarcoma cells
title_full_unstemmed The palladacycle complex AJ-5 induces apoptotic cell death while reducing autophagic flux in rhabdomyosarcoma cells
title_short The palladacycle complex AJ-5 induces apoptotic cell death while reducing autophagic flux in rhabdomyosarcoma cells
title_sort palladacycle complex aj-5 induces apoptotic cell death while reducing autophagic flux in rhabdomyosarcoma cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349869/
https://www.ncbi.nlm.nih.gov/pubmed/30701092
http://dx.doi.org/10.1038/s41420-019-0139-9
work_keys_str_mv AT blelochjennasusan thepalladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT dutoitandre thepalladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT gibhardliezl thepalladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT kimaniserah thepalladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT ballimreynadeeya thepalladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT leeminkyu thepalladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT blanckenbergangelique thepalladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT mapolieselwyn thepalladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT wiesnerlubbe thepalladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT loosben thepalladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT princesharon thepalladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT blelochjennasusan palladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT dutoitandre palladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT gibhardliezl palladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT kimaniserah palladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT ballimreynadeeya palladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT leeminkyu palladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT blanckenbergangelique palladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT mapolieselwyn palladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT wiesnerlubbe palladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT loosben palladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells
AT princesharon palladacyclecomplexaj5inducesapoptoticcelldeathwhilereducingautophagicfluxinrhabdomyosarcomacells